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Abstract: 
Two chromatographic methods were developed and validated for the simultaneous determination of Sodium Cromoglycate 
(SCG) and Oxymetazoline Hydrochloride (OXMT). SCG and OXMT are administered in combination for effective 
treatment of nasal congestion and allergy. The first chromatographic method was based on usingaluminum TLC plates 
pre-coated with silica gel GF254 as the stationary phase and chloroform: methanol: toluene: triethylamine (5: 2: 4:1, by 
volume) as the mobile phase followed by densitometric measurement of the separated bands at 235 nm. The second 
method is a high performance liquid chromatographic method for separation and determination of SCG and OXMT using 
reversed phase C18 column with isocratic elution. The mobile phase composed of acetonitrile: methanol (2: 1, v/v) at flow 
rate of 1.0 mL/ min. Quantitation was achieved with UV detection at 220 nm. The validity of the proposed methods was 
assessed using the standard addition technique. The obtained results were statistically compared with those obtained by 
the official methods, showing no significant difference with respect to accuracy and precision at p = 0.05. 
Keywords: Sodium cromoglycate; Oxymetazoline hydrochloride; TLC-densitometry; high performance liquid 
chromatography. 
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Introduction 
Chemically, sodium cromoglycate (SCG) is 5,5′-(2-hydroxypropane-1,3-diyl)bis(oxy)bis(4-oxo-4H-chromene-2-carboxylic 
acid) disodium salt (Fig. 1a). It exerts its action via preventing the release of mediators that would normally attract 
inflammatory cells. [1] Oxymetazoline hydrochloride (OXMT) is chemically designated as 3-(4,5-dihydro-1H-imidazol-2-
ylmethyl)-2,4-dimethyl-6-tert-setyl-phenol hydrochloride salt (Fig. 1b). It is a sympathomimetic agent that selectively acts 
on α1 and partially on α2 adrenergic receptors. [2]  Both drugs are co-formulated in a nasal spray dosage form and are 
widely used for effective treatment of nasal congestion and allergy. Several methods have been reported for the 
determination of SCG in pharmaceutical preparations such as spectrophotometry [3, 4], electrophoresis [5], 
electrochemical [6, 7] and HPLC methods. [8-14] OXMT has also been analyzed by several methods in pharmaceutical 
preparations such as spectrophotometry [3, 15-23], capillary electrophoresis [24, 25], gas chromatography [26, 27] and 
HPLC. [28-35] Abdel-Aziz et al. [3] developed new accurate, sensitive and selective spectrophotometric and 
spectrofluorimetric methods for determination of SCG and OXMT. To the best of our knowledge, no reported 
chromatographic methods were found for simultaneous determination of the cited drugs in their combination. The aim of 
this work is to develop simple chromatographic methods for the simultaneous determination of SCG and OXMT in 
pharmaceutical dosage form. 
Experimental 
2.1.  Instruments 
The thin-layer chromatographic (TLC) system consisted of a Camag Linomat autosampler (Muttenzl, Switzerland), a 
Camag microsyringe (100 mL) and a Camag 35/N/30319 TLC scanner with win CATS software; an ultraviolet (UV) lamp 
with a short wavelength at 254 nm (Desaga, Wiesloch, Germany); and TLC plates precoated with silica gel G.F254 10×20 
cm, 0.25 mm thickness (Merck, Darmstadt, Germany).  
HPLC system consisted of Agilent 1100 series liquid chromatograph, Waldbornn, Germany. It consists of Isocratic pump-
model G 1310 A, UV detector–Model G 1314 A, A Rheodyne injector–Model 7225/77251, (Rohnert park, CA, USA) 
Equipped with a prominence Autosampler (modelSIL-20A). C18, Zorbax Eclipse XDB (4.6 × 150 mm), particle size (5 µm), 
USA. 
2.2. Materials and reagents 
2.2.1. Pure standard 
SCG pure sample was supplied by SIGMA Pharmaceutical industries, Egypt. Pure sample of OXMT was supplied by 
National Organization for Drug Control and Research (NODCAR), Egypt. Their purity were checked and found to be 101.5 
± 1.01 and 99.93 ± 1.01 for SCG and OXMT, respectively, according to the USP reference methods [36] which are 
spectrophotometric and HPLC methods for SCG and OXMT, respectively.  
2.2.2. Pharmaceutical dosage form 
Nasocrom ® nasal spray (SIGMA Pharmaceutical industries, Egypt), labeled to contain 2g of SCG and 0.025g of OXMT 
per 100 mL (Batch number: 11087) was obtained from the local market. 
2.2.3. Chemicals and reagents 
All chemicals used throughout the work were of analytical grade and solvents for HPLC were of HPLC grade. These 
included methanol, chloroform, triethylamine and acetonitrile (Sigma-Aldrich, Belgium), and double distilled deionized 
water (Otsuka, Cairo, Egypt). Toluene was purchased from Al-Nasr Pharmaceutical Chemicals Co., Cairo, Egypt.  
2.2.4. Standard solutions 
Standard stock solution of each of SCG and OXMT: 1.0 mg/mL in methanol (for TLC method) and 10 mg/mL of SCG and 
1.0 mg/mL OXMT in mobile phase(for HPLC method). 
2.2.5. Working Solutions 
For HPLC method. Working solutions of SCG (1.0 µg/mL) and OXMT (100µg/mL) were prepared from their respective 
stock solutions using mobile phase as a solvent. 
2.3. Procedures 
2.3.1. Construction of the calibration curves 
For TLC-spectrodensitometric method. 
Accuratly measured aliquots of SCG and OXMT stock standard solution (1mg/mL) were spotted onto two different TLC 
plates using Camag Linomat autosampler with microsyringe (100 μL). The plates were then developed by the ascending 
technique using chloroform: methanol: toluene: triethylamine (5: 2: 4:1, by volume) as a mobile phase. The plates were 
then removed and air-dried. The chromatogram was scanned at 235 nm. Calibration curves representing the relationship 
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between integrated peak area and the corresponding concentrations of each of SCG (0.4-4.4 μg/band) and OXMT (0.5-
20.0 μg/band) were plotted. 
2.3.2. For HPLC method:  
Aliquots of SCG and OXMT equivalent to 900-8000 µg and 100-900 µg, respectively, where separately and accurately 
transferred each from its respective working standard solution (1.0 mg/mL SCG and 0.1 mg/mL OXMT) into three separate 
sets of 10-mL measuring flasks and the volume was then completed to the mark with the mobile phase (acetonitrile: 
methanol (2: 1, v/v)). A 20-µL aliquot of each solution was injected into an C18, Zorbax Eclipse XDB (4.6 × 150 mm), 
particle size (5 µm), using the mobile phase, at flow rate 1.0 mL/min and UV detection at 220 nm. Two calibration curves 
were constructed by plotting the relative peak area, using an external standard of 400 µg/mL SCG and 50 µg/mL OXMT, 
against the corresponding concentrations of each drug. 
2.3.3. Application to pharmaceutical formulations  
Appropriate dilutions from Nasocrom® nasal drops were made using methanol to obtain solutions having concentrations 
within the linearity range of each of SCG and OXMT, these dilutions were analyzed by the proposed chromatographic 
methods as detailed under linearity. The concentrations of SCG and OXMT were obtained from the computed regression 
equations and the validity of the methods was further assessed by applying the standard addition technique 
Results  
Several trials were conducted to develop the optimum chromatographic conditions for the sufficient separation of both 
drugs. The results of the TLC system were satisfactory when using chloroform: methanol: toluene: triethylamine (5: 2: 4:1, 
by volume)as the mobile phase. Rf values were found to be 0.1±0.01 and 0.3±0.01 for SCG and OXMT, respectively as 
shown in (Fig. 2). This separation allows the determination of SCG and OXMT at 235 nm without any interference from 
each other. 
HPLC method was also tried to separate SCG and OXMT, therefore several trials have been undertaken to reach the 
optimum stationary/mobile phases matching. Good chromatographic separation of the two drugs in their binary mixtures 
could be achieved by using an C18, Zorbax Eclipse XDB (4.6 × 150 mm), particle size (5 µm), with a mobile phase 
consisting of (acetonitrile: methanol (2: 1, v/v)) at flow rate 1.0 mL/min, followed by UV detection at 220 nm, (Fig. 3). 
Calibration was performed for both TLC and HPLC for the determination of the cited drugs. An overall system suitability 
testing was calculated (Table I) to determine whether the operating system performed properly. The proposed methods 
were validated according to International Conference on Harmonization (ICH) guidelines (Table II). The table also shows 
the assay parameters of the regression equations and the ranges of concentration.  
The proposed methods were successfully applied for determination of SCG and OXMT in Nasocrom
®
 nasal spray. The 
results shown in table (III) were satisfactory. The validity of the proposed methods was assessed by applying the standard 
addition technique, no interference due to excipients was observed as shown from the results in table (III). 
The results obtained by applying the proposed methods for analysis of pure SCG and OXMT compared to those obtained 
by applying the official methods [36], they showed no significance difference regarding accuracy and precision table (IV). 
Discussion 
Planar chromatography with precise application of the samples and computer controlled evaluation and quantification of 
the developed chromatograms has been considered to be a reliable technique for purity control and for quantitative drug 
testing [37]. Therefore the aim of this work is to develop simple, accurate, rapid, specific and valid spectro-densitometric 
method. This separation allows the determination of SCG and OXMT without any interference from each other.   Linear 
relationship was found to exist between the integrated peak area of the separated bands at the selected wavelength (235 
nm) and the corresponding concentration of SCG in the range of 0.4-4.4 μg/band and a polynomial one was found in the 
range of 0.5-20.0 μg/band for OXMT, figures (19, 20).  
The regression equations were computed and found to be:  
A= 0.375X + 0.309                                        r = 0.9999       for SCG 
A= - 0.003X2 + 0.219X + 0.282                              r =0.9990      for OXMT 
Where A, is the integrated peak area x 10-4, X is the concentration in μg/band and r is the correlation coefficient.  
The suggested chromatographic system for the HPLC method allows complete base line separation at reasonable time. 
The linearity of the detector’s response of the studied drugs was determined by plotting relative peak area (calculated 
following the external standard technique using 400 µg/mL SCG and 50 µg/mL OXMT as the external standards for SCG 
and OXMT, respectively) versus concentrations and linear correlation was obtained. The regression equations were 
computed for SCG and OXMT and found to be: 
A = 0.002 X + 0.059                     r = 1.0000                                for SCG 
A = 0.020 X + 0.010                       r = 0.9995                              for OXMT 
Where, A is the relative peak area, X is the drug concentration in µg/mL and r is the correlation coefficient. 
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2.4. Method Validation 
The proposed methods were validated according to the ICH Q2 (R1)recommendations [38]. The method was validated for 
parameterssuch as system suitability, linearity, limit of detection (LOD), limit of quantitation (LOQ), accuracy, precision and 
selectivity. 
2.4.1. System suitability 
The system suitability test is an integral part of chromatographic method development and it is used to verify that the 
systemis adequate for the analysis to be performed; the parameters Q8 for SCG and OXMT were evaluated. The 
suitability of the chromatographics ystem was determined according to USP guidelines and with acceptance of the 
obtained parameter values. [36]  
2.4.2. Linearity and ranges 
Under the above mentioned experimental conditions, linear relationships were obtained by plotting the drug concentrations 
either against integrated peak areas or relative peak areas for each drug, for TLC  and HPLC methods, respectively.  
2.4.3. Accuracy 
The accuracy of the proposed methods was validated by analyzing pure samples of each SCG and OXMT in triplicate. 
The concentrations of the active drugs were calculated from the corresponding regression equations. 
2.4.4. Precision 
It was evaluated by calculating intra and inter-day precision. By repeating the assay of three different concentrations of 
each of the cited drugs three times in the same day and assaying the same samples in triplicate on three successive days 
using the developed chromatographic methods. RSD values were then calculated for each sample. 
2.4.5. Specificity 
The specificity of the developed methods was investigated by application of mixtures containing the two drugs in different 
ratios to TLC plate and the method under the chromatographic conditions were then followed. The bands of the two drugs 
in the prepared mixtures were confirmed by comparing their Rf values with that of standard drugs solutions. (in TLC 
method). Specificity was ascertained by analyzing different mixtures containing SCG and OXMT in different ratios. 
Parameters such as resolution, capacity and selectivity factors for the separated chromatographic peaks were then 
calculated (in HPLC method). 
Conclusion 
The suggested chromatographic methods provide simple, sensitive, accurate and reproducible methods for quantitative 
analysis of SCG and OXMT in their binary mixtures and pharmaceutical dosage form.  The developed TLC method is 
highly sensitive. It has the advantages of short run time, large sample capacity and use of minimal volume of solvents. 
HPLC method gives a good resolution between the proposed components within suitable analysis time; it is highly specific 
but more expensive.  
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Table I: Parameters required for system suitability test of TLC-densitometric and HPLC methods. 
 
 TLC-Densitometric 
method 
HPLC method Reference values 
 SCG OXMT SCG OXMT  
R e t e n t i o n  t i m e  ( t R )  [ m i n ]   1.49 2.67 
R e t a r d a t i o n  f a c t o r  ( R f )  0.1 0.3  
T a i l i n g  f a c t o r  ( T ) 0.9 0.87 0.98 0.92 
T =1, for a typical 
symmetrical peak 
C a p a c i t y  f a c t o r  ( K ' ) 9.0 7.0 2.34 7.10 1<K’<10 
S e l e c t i v i t y  f a c t o r  ( α ) 1.29 3.03 α > 1 
R e s o l u t i o n  f a c t o r  ( R s )  5.14 3.38 Rs > 1.5 
C o l u m n  e f f i c i e n c y  ( N )  
 256 3364 Increase with the 
efficiency of the 
separation 
H E T P  a   [ m m ] 
0.098 0.0074 The smaller the value 
the higher the column 
efficiency 
 
HETP 
a 
= height equivalent to theoretical plates (length of column in mm/ N). 
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Table II: Assay validation sheet of the proposed methods for the simultaneous determination of Sodium 
cromoglycate (SCG) and Oxymetazoline hydrochloride (OXMT). 
 
a
The intraday RSD % and 
b
 The inter-day RSD %, for TLC RSD% of three concentrations (1.50, 2.50 and 3.50 
μg/band)  of SCG and (3.50, 5.50 and 7.50 μg/band) of OXMT repeated three times within the day. For HPLC 
RSD% of three concentrations (90.00, 150.00 and 500.00 µg/mL) of SCG and (10.00, 50.00 and 80.00 µg/mL) 
of OXMT repeated three times within the day. 
 
 
 
 
 
 
Parameters 
TLC-Densitometric method HPLC method 
SCG OXMT SCG 
OXMT 
Range 
0.4-4.4 μg/band 0.5-20.0 μg/band 
90-800 µg/mL 10-90 µg/mL 
Slope 1 0.375 -0.003 0.002 0.020 
Slope 2 ------ 0.219 ----- ---- 
Intercept 0.309 0.282 0.059 0.010 
SE of the slope 
0.0084 
 
0.0045 
 
0.0003 
        0.0002 
SE of the intercept 
0.0232 0.0525 
 
0.0136          0.0127 
Correlation coefficient (r) 0.9999 0.9990 1.0000 0.9995 
LOD 
0.100 (µg/band) 
 
0.150 (µg/band) 
 
29.16 µg/mL 2.71 µg/mL 
LOQ 
0.400 (µg/band) 
 
0.500 (µg/band) 
87.48 µg/mL 8.12 µg/mL 
Accuracy  
(Mean ± RSD) 
100.67±1.805 
99.63±1.290 100.71± 1.652 99.65±1.154 
Precision (RSD) 
Repeatability 
Intermediate precision 
0.998 
1.709 
1.520 
2.400 
1.988 
2.551 
1.023 
0.984 
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Table III: Determination of Sodium cromoglycate (SCG) and Oxymetazoline hydrochloride (OXMT) in their 
Dosage form and application of standard addition technique using the proposed methods. 
 
a
Average of three determinations of dosage form. 
b
Average of three determinations of dosage form after the addition of different amounts of SCG or OXMT  
pure standard (standard addition technique). 
 
Table IV: Statistical comparison for the results obtained by the proposed methods and the official methods 
for the analysis of Sodium cromoglycate (SCG) and Oxymetazoline hydrochloride (OXMT). 
  
* These values represent the corresponding tabulated values of t and F at P=0.05 
** "The National Formulary USP" United States Pharmacopeia convention Inc. 2011. 
a) Direct absorbance measurement at λmax 326 nm using Sodium phosphate buffer (pH 7.4) as a blank. 
b) HPLC method; mobile phase [water: methanol: 1M sodium acetate: glacial acetic acid (46:40: 10:4)] with 
UV detection at 280 nm 
  
Nasocrom® nasal drops  
 
B. N. 80724 
T L C     H P L C 
S C G 
O X M T   S C G O X M T 
Mean Recovery a         ± RSD 104.00±1.351 100.83±2.100 
 
103.56 ±0.630 101.16±0.960 
Standard additionb(mean±RSD)  99.45±1.141 100.73±1.548   99.00±0.006 100.63±1.475 
P a r a m e t e r 
T L C    H P L C   O f f i c i a l  m e t h o d
* * 
SCG OXMT   SCG OXMT   SCG
 (a)
 OXMT 
(b)
 
         
Mean 100.67 99.63 
 
100.71 99.65 
 
101.50 99.93 
SD 1.818 1.285 
 
1.664 1.150 
 
1.005 1.005 
Variance 3.303 1.652 
 
2.769 1.322 
 
1.010 1.010 
n 5 5 
 
5 5 
 
5 5 
Student’s t 
test 
(2.3060)*         
0.889 0.410 
 
0.914 0.408 
   
F value 
(6.3882)* 
3.271 1.636 
 
2.742 1.309 
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Figure 1: Chemical structures of (a) sodium cromoglycate and (b) oxymetazoline hydrochloride 
 
Fig. 2: TLC chromatogram of mixture of Sodium Cromoglycate (SCG) (RF=0.10±.0.01) and 
Oxymetazoline Hydrochloride (OXMT) (RF=0.30±0.01) at 235 nm using chloroform: methanol: toluene: 
triethylamine (5: 2: 4:1, by volume) as a developing system. 
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Fig. 3: HPLC chromatogram of a resolved mixture of Sodium Cromoglycate (SCG) (tR=1.49) and 
Oxymetazoline Hydrochloride (OXMT) (tR=2.67) using mobile phase of acetonitrile: methanol (2: 1, 
v/v). 
 
 
 
 
 
 
 
 
 
 
 
 
 
